• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Krueppel-like factor 16 (KLF16)

ACP11604

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11604 Target NameKLF16
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-252Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BXK1
Background Information
  • Uniprot Id

    Q9BXK1

  • Target Species

    Human

  • Target Name

    KLF16

  • Target Full Name

    Krueppel-like factor 16

  • Target Function

    Transcription factor that binds GC and GT boxes and displaces Sp1 and Sp3 from these sequences. Modulates dopaminergic transmission in the brain.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    Sp1 C2H2-type zinc-finger protein family

  • Target Synonyms

    AI843742; Basic transcription element binding protein 4; Basic transcription element-binding protein 4; BTE binding protein 4; BTE-binding protein 4; BTEB 4; BTEB4; Dopamine receptor regulating factor; DRRF; KLF 16; Klf16; KLF16_HUMAN; Krueppel-like factor 16; Kruppel like factor 16; Likely ortholog of mouse dopamine receptor regulating factor; MGC187751; Novel Sp1 like zinc finger transcription factor 2; Novel Sp1-like zinc finger transcription factor 2; NSLP 2; NSLP2; RCG29340 ; Transcription factor BTEB 4; Transcription factor BTEB4; Transcription factor NSLP 2; Transcription factor NSLP2

Inquire Recombinant Human Krueppel-like factor 16 (KLF16) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification